RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Paul Wang to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications Paul Wang has written about Radiopharmaceuticals.
Paul Wang
Connection Strength
0.092
Radiopharmaceuticals
  1. Meng J, Wang DL, Wang PC, Jia L, Chen C, Liang XJ. Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics. J Nanosci Nanotechnol. 2010 Dec; 10(12):8610-6.
    View in: PubMed
    Score: 0.092
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support